Commodore Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-893,646
| Closed | -$43.3M | – | 36 |
|
|
2022
Q3 | $43.3M | Hold |
893,646
| – | – | 6.96% | 6 |
|
|
2022
Q2 | $35.1M | Buy |
893,646
+38,994
| +5% | +$1.53M | 7.42% | 5 |
|
|
2022
Q1 | $31.5M | Buy |
854,652
+150,115
| +21% | +$5.53M | 7.03% | 6 |
|
|
2021
Q4 | $32.1M | Sell |
704,537
-92,041
| -12% | -$4.2M | 7.44% | 5 |
|
|
2021
Q3 | $28.5M | Buy |
796,578
+92,261
| +13% | +$3.3M | 7.51% | 3 |
|
|
2021
Q2 | $13.9M | Buy |
+704,317
| New | +$13.9M | 4.86% | 7 |
|